Human epidermal growth factor receptor 2 (HER2), a member of the epidermal growth factor receptor (EGFR/HER) family, is a transmembrane tyrosine kinase receptor that is overexpressed in approximately 20–30% of breast and gastric cancers, as well as in subsets of other solid tumors (1). The gene discussed is ERBB2; the disease is gastric cancer.